BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Esperion Therapeutics (1) is defunct.

Fate: Acquired by Pfizer early 2004 $1.3B.


------------------
If you believe any of this information is incorrect, please let us know.